The Week's Biggest Stock Laggards

So far, 2012 has been a swell year for investors, as stocks have taken off. Over the past week, we saw markets cheering a proposal by the International Monetary Fund to raise $600 billion in new funds to help it address the eurozone debt crisis. Strong earnings results from financial companies such as Goldman Sachs and Bank of America as well as tech bellwethers such as IBM and Intel also helped drive stocks forward.

For the week, the Dow Jones Industrial Average (INDEX: ^DJI  ) tacked on 2.4%, while the broader Russell 3000 added 2.1%. Earnings in specific sectors had a lot to do with sector performance this week, but broadly, defensive sectors had a tough time keeping up with the rest of the market.

The 3 Worst-Performing Sectors

Russell 3000 Sector

Weekly Price Change

Month-to-Date Price Change

Utilities (0.1%) (0.6%)
Telecom 0.1% 0%
Materials 0.5% 2.4%

Source: S&P Capital IQ. Weekly price change is Jan. 13-Jan. 20. Monthly price change is Dec. 30-Jan. 20.

Though the utility sector was the worst performer this week, most utilities didn't fare nearly as badly as GenOn Energy (NYSE: GEN  ) . The Houston-based electricity generator hasn't exactly been an investor favorite as it is, and the stock has been clobbered over the past year. This week, though, the shares were nailed by a downgrade to sell from UBS and an initial rating of underweight from Morgan Stanley -- on the same day.

As poorly as GenOn shares fared, biopharma Achillion Pharmaceuticals (Nasdaq: ACHN  ) managed to have an even worse showing. The stock was hit by a very critical article on Seeking Alpha that reviewed some of the recent action around hepatitis C drug developers and then laid the smackdown on Achillion, saying that the company is set to be left in the dust by its competitors because of types of hep-C treatments that it's working on. Shares fell 11% for the day following the publishing of the article.

The 3 Worst-Performing Russell 3000 Companies

Company

Weekly Price Change

Achillion (23%)
R.R. Donnelley (15%)
GenOn (15%)

Source: S&P Capital IQ. Weekly price change is Jan. 13-Jan. 20. Includes only companies with market caps of $250 million or more.

Also among the week's worst performers were Johnson Controls (NYSE: JCI  ) and Fulton Financial (Nasdaq: FULT  ) . It's earnings season, and that means investors need to be ready to dance along with the market as it alternately celebrates and slams stocks based on whether they're pennies above or pennies below Wall Street analysts' estimates. For Johnson Controls, the big reveal showed that it was pennies short for its fiscal first quarter. Earnings per share of $0.60 limboed analyst expectations of $0.62. Worse still, the company cut its full-year profit outlook from a range of $2.85 to $3 per share to a range of $2.70 to $2.85.

For Fulton Financial, it was a similar fate. Earnings per share clocked in at $0.18, which was a 12.5% increase from the fourth quarter of 2010, but it was also $0.02 shy of the target that Wall Street had set. By the time the smoke cleared for the week, Fulton's stock had shed just north of 10%.

That's it for the weekly-laggards recap. Looking to turn the tides and find some strong outperformers in the year ahead? The Motley Fool has created a brand new free report titled "The Motley Fool's Top Stock for 2012." In it, my fellow Fools reveal a top pick that's poised for explosive growth ahead. Get instant access -- it's free.

The Motley Fool owns shares of IBM, Intel, and Bank of America. Motley Fool newsletter services have recommended buying shares of Intel. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Fool contributor Matt Koppenheffer owns shares of Intel, Bank of America, and GenOn but has no financial interest in any of the other companies mentioned. You can check out what Matt is keeping an eye on by visiting his CAPS portfolio, or you can follow Matt on Twitter, @KoppTheFool, or on Facebook. The Fool's disclosure policy prefers dividends over a sharp stick in the eye.


Read/Post Comments (0) | Recommend This Article (10)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1762718, ~/Articles/ArticleHandler.aspx, 11/28/2014 8:42:01 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement